EUCTR2016-002372-27-HU进行中（未招募）1 期
Administration of blinatumomab to one pediatric patient
BAZ Megyei és Egyetemi Oktató Kórház0 个研究点目标入组 1 人开始时间: 2016年5月31日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 1
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic LeukemiaB-Cell Lymphoblastic LeukemiaNCT06607419Shanghai Jiao Tong University School of Medicine90
招募中
1 期
Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)Pediatric ALL, B CellMinimal Residual DiseaseNCT04604691Seoul National University Hospital20
已完成
1 期
Phase I trial of nivolumab in pediatric patients with malignant solid tumors or Hodgkin lymphomaPediatric malignant solid tumors, Hodgkin lymphomaJPRN-UMIN000026497ational Cancer Center26
招募中
3 期
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute LeukemiaAcute Lymphoblastic LeukemiaMixed Phenotype Acute LeukemiaNCT05327894Princess Maxima Center for Pediatric Oncology160
尚未招募
不适用
NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALLB Cell Precursor Acute Lymphoblastic LeukemiaPediatricNext Generation Sequencing (NGS)Minimal Residual DiseaseNCT06763302The Children's Hospital of Zhejiang University School of Medicine1,220